TEH Bin Tean

Institute of Molecular and Cell Biology, A*STAR, Singapore

Dr Teh obtained his MD (1992) from the University of Queensland, Australia and his PhD (1997) from the Karolinska Institute, Sweden. His laboratory focuses on Genomics of Asian-Prevalent Cancers including hepatobiliary cancer, herbal carcinogen-related cancer and fibroepithelial tumors of the breast. Dr Teh has published extensively, with over 400 peer-reviewed publications. He is a past and present member of numerous editorial boards for journals including Lancet Oncology, Science Translational Medicine, Cancer Research, Molecular Cancer Therapeutics. Dr Teh is a recipient of the 2015 SingHealth Distinguished Researcher Award, 2015 Singapore President Science Award, 2018 AACR (American Association of Cancer Research) Team Science Award and 2021 JCA (Japanese Cancer Association) International Award.